Quarterly report · Q2
4521.TEDINET S100S89K
Period2023-04-01 → 2023-09-30
Filed2023-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥36.2bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥73.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥36.8bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥5.5bn | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥8.2bn | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥5.7bn | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥8.7bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥8.6bn | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥5.7bn | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥8.2bn | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥4.1bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥5.4bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥6.0bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥4.1bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥6.0bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥171.7bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥166.3bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥167.3bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥30.9bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥29.5bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥140.7bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥136.8bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥140.4bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥55.4bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥59.6bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥70.1bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥74.3bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥75.5bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥74.6bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥245m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥9.3bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥6.4bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥1.1bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.6bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.4bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥2.8bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥7.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥4.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥108.18 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥41.29 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥144.8 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥158.34 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥81.45 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 82.0% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 81.9% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 83.6% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 18
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E00935-000Medicinereportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥35.0bn |
| jpcrp040300-q2r_E00935-000Medicinereportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥35.0bn |
| jpcrp040300-q2r_E00935-000Medicinereportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥4.9bn |
| jpcrp040300-q2r_E00935-000Real Estatereportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥1.2bn |
| jpcrp040300-q2r_E00935-000Real Estatereportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥1.2bn |
| jpcrp040300-q2r_E00935-000Real Estatereportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥661m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥36.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥36.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥5.5bn |
| jpcrp040300-q2r_E00935-000Medicinereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥35.6bn |
| jpcrp040300-q2r_E00935-000Medicinereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥35.6bn |
| jpcrp040300-q2r_E00935-000Medicinereportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥7.6bn |
| jpcrp040300-q2r_E00935-000Real Estatereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥1.2bn |
| jpcrp040300-q2r_E00935-000Real Estatereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥1.2bn |
| jpcrp040300-q2r_E00935-000Real Estatereportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥616m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥36.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥36.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥8.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 501
| Item | Context | Value | Unit |
|---|---|---|---|
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都文京区本駒込二丁目28番８号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)03(5977)5007(ダイヤルイン) | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)経理部長 伊 東 誠 司 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都文京区本駒込二丁目28番８号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)03(5977)5007(ダイヤルイン) | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)経理部長 伊 東 誠 司 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E00935 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 45210 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)科研製薬株式会社 | |
| Filer name in english | FilingDateInstant | KAKEN PHARMACEUTICAL CO., LTD. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Current fiscal year start date | FilingDateInstant | 2023-04-01 | |
| Current period end date | FilingDateInstant | 2023-09-30 | |
| Type of current period | FilingDateInstant | Q2 | |
| Current fiscal year end date | FilingDateInstant | 2024-03-31 | |
| Previous fiscal year start date | FilingDateInstant | 2022-04-01 | |
| Comparative period end date | FilingDateInstant | 2022-09-30 | |
| Previous fiscal year end date | FilingDateInstant | 2023-03-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of group (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts for operation (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 | |
| Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registered | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)東京証券取引所プライム市場 | |
| Description issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)単元株式数は100株であります。 | |
| Details of employee share option program (text) | FilingDateInstant | Text · Plus | |
| Other information on share acquisition rights (text) | FilingDateInstant | Text · Plus | |
| Exercises etc of moving strike convertible bonds etc (text) | FilingDateInstant | Text · Plus | |
| Changes in number of issued shares stated capital etc (text) | FilingDateInstant | Text · Plus | |
| Major shareholders (text) | FilingDateInstant | Text · Plus | |
| Name major shareholders | CurrentQuarterInstant_No1MajorShareholdersMember | Original text (Japanese)日本マスタートラスト信託銀行株式会社(信託口) | |
| Address major shareholders | CurrentQuarterInstant_No1MajorShareholdersMember | Original text (Japanese)東京都港区浜松町２－11－３ |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |